Evidence that iron overload plus croton oil induce skin tumours in mice

Human and Experimental Toxicology

Volumn 24, Issue 8, 2005, Pages 409-413

  Rezazadeh, Hassan ^a   Nayebi, A R ^a   Garjani, A ^a   Sheikhulislami, A ^a   Babaei, H ^b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Croton oil; Iron overload; Skin tumorigenesis

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; ACETONE; CROTON OIL; IRON; IRON DEXTRAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENETIC DISORDER; IRON OVERLOAD; LIPID PEROXIDATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SKIN CARCINOGENESIS; SKIN TUMOR;

ANIMALS; CARCINOGENS; COCARCINOGENESIS; CROTON OIL; FEMALE; IRON; LIPID PEROXIDATION; MICE; SKIN NEOPLASMS;

ANIMALIA;

EID: 23944495803     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1191/0960327105ht544oa     Document Type: Article

References (28)

1. Conard ME, Uzel C, Berry M, Latour L. Ironic catastrophes; one's food another's poison. Am J Med Sci 1994; 307: 434-37.
2. Herbert V, Shaw S, Javatilleke E, Stopler KT. Most free radical injury is iron-related: it is promoted by iron, hematin, holoferritin and vitamin C and inhibited by desferroxamine and apoferritin. Stem Cells 1994; 12: 289-303.
3. Gordeuk VR, Boyd RD, Brittenham GM. Dietary iron overload persist in rural sub-Saharan Africa. Lancet 1986; 1: 1310-13.
4. Ponka P. Rare causes of hereditary iron overload. Sem Hematol 2002; 4: 249-62.
5. Hash RB. Hereditary haemochromatosis. J Am Board Fam Pract 2001; 4: 266-73.
6. Dadone M, Kushner JP, Edwards CQ, Bishop DT, Skolnick MH. Hereditary haemochromatosis: analysis of laboratory expression of the disease by genotype in 18 pedigrees. Am J Clin Pathol 1982; 78: 196-207.
7. Gordeuk VR, Bacon BR, Brittenham GM. Iron overload: causes and consequences. Ann Rev Nutr 1987; 7: 485-503.
8. Bothwell TH, Seftel H, Jacobs P, Torrance JD, Baumslag N. Iron overload in Bantu subjects. Studies on availability of iron in Bantu beer. Am J Clin Nutr 1964; 14: 47-51.
9. Mclaren GD, Muir WA, Kellermeyer RW. Iron overload disorders: natural history, pathogenesis, diagnosis and therapy. Crit Rev Clin Lab Sci 1983; 19: 205-66.
10. Stevens RG, Granbard BI, Micozzi MS, Neriishi K, Blumberg BS. Moderate elevation attention of body iron level and increased risk of cancer occurrence and death. Int J Cancer 1994; 56: 364-69.
11. Selby JV, Friedman GD. Epidemiologic evidence of an association between body iron stores and risk of cancer. Int J Cancer 1988; 41: 677-82.
12. Rezazadeh H, Athar M. Evidence that iron overload promotes 7,12-dimethylbenz(a)antheracene-induced skin tumorigenesis in mice. Redox Rep 1998; 3: 303-9.
13. Rezazadeh H, Julka PK, Athar M. Iron overload augments 12,7-dimethylbenz(a)anthracine-initiated and 12-O-tetradecanoylphorbol-13- acetate-promoted skin tumorigenesis. Skin Pharmacol Appl Skin Physiol 1998; 11: 98-103.
14. Rezazadeh H, Athar M. Effect of iron overload on benzoyl peroxide-mediated tumour promotion in mouse skin. Cancer Letts 1998; 126: 135-42.
15. Rezazadeh H, Nayebi AR, Athar M. Role of iron-dextran on 7,12-dimethylbenz(a) anthracene-initiated and croton oil-promoted cutaneous tumorigenesis in normal and pregnant mice. Hum Exp Toxicol 2001; 20: 471-76.
16. Delazar A, Babaei H, Rezazadeh H. Inhibitory effect of tannic acid from nutgall on iron-dextran augmented 7,12-dimethylbenz(a) anthracene-initiated and croton oil-promoted skin carcinogenesis. Daru J Fac Pharm Tehran Univ Med Sci 2003; 11: 63-7.
17. Wright JR, Colby HD, Miles PR. Cytosolic factors which affect microsomal lipid peroxidation in lung and liver. Arch Biochem Riophys 1981; 206: 296-304.
18. Perchellet EM, Gali HU, Gao XM, Perchellet JP. Ability of the nonphorbol ester-type tumour promoter thapsiagargin to mimic the stimulatory effects of 12-O-tetradecanoylphorbol-13-acetate on ornithine decarboxylase activity, hydroperoxide production, and macromolecule synthesis in mouse epidermis in vivo. Int J Cancer 1993; 55: 1036-43.
19. Kano S, Iisuka T, Ishimura Y, Fujiki H, Sugimura T. Stimulation of superoxide anion formation by the non-TPA-type tumour promoters palytoxin and thapsigargin in porcine and human neutrophils. Biochem Biophys Res Commun 1987; 143: 672-77.
20. Gaey CI, Ziboh VA, Marcelol CI, Voorhees JJ. Modulation of phospholipid metabolism in murine keratinocytes by tumour promoters 12-O-tetradecanoyl phorbol 13-acetate. J Invest Dermatol 1985; 85: 319-23.
21. Ford-Hutchinson AW. Arachidonic acid metabolism: enzymatic pathways. In Ruzick T ed. Eicosanoids and the skin. Boca Raton, FL: CRC Press, 1990: 3.
22. Sun Y. Free radicals, antioxidant enzymes and carcinogenesis. Free Rad Biol Med 1990; 8: 583-99.
23. Cerutti P. Prooxidant states and tumour promotion. Science 1985; 227: 375-81.
24. Fukuda A, Osawa T, Hitomi K, Uchida K. 4-Hydroxy-2-nonenal cytotoxicity in renal proximal tubular cells: protein modification and redox alteration. Arch Biochem Biophys 1996; 333: 419-26.
25. Toyokuni S, Miyake N, Hiai H, Hagiwara M, Kawakishi S, Osawa T, Uchida K. The monoclonal antibody specific for the 4-hydroxy-2-nonenal histidine adduct. FEBS Letts 1995; 359: 189-91.
26. Toyokuni S, Uchida K, Okamato K, Hattori-Nakakuki Y, Hiai H, Stadtman ER. Formation of 4-hydroxy-2-nonenal modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate. Proc Natl Acad Sci USA 1994; 91: 2616-20.
27. Giri U, Sharma SD, Abdulla M, Athar M. Evidence that in situ generated active oxygen species act as potent stage-I tumour promoter in mouse skin. Biochem Biophys Res Commun 1995; 209: 698-705.
28. Kramer-Stickland K, Edward A. Inhibitory effect of deferoxamine on UVB-induced Ap-1 trans activation. Carcinogenesis 1999; 20: 2137-42.